Rasagilin - 雷沙吉兰

Rasagiline is a selective, irreversible monoamine oxidase type B (MAO-B) inhibitor that works by reducing the breakdown of dopamine in the brain, thereby increasing dopamine levels. It is primarily used in the treatment of Parkinson's disease, either as monotherapy in early-stage disease or as an adjunctive therapy to levodopa to help improve motor symptoms and reduce "off" time fluctuations.

Please consult your physician for appropriate dosage.